Accelerate Today, Expand Tomorrow: Discover the EVOQ® DART-TQ+ featuring RECIPE's ClinMass Kits now and ClinDART just ahead
Redefining Clinical Research Assays
Mass spectrometry enables sensitive, accurate, and precise analysis of complex samples, outperforming conventional technologies. Bruker's EVOQ® DART-TQ+ brings the power of Triple Quadrupole Mass Spectrometry (TQ-MS) to clinical research in a fast, easy-to-use system. In collaboration with RECIPE Chemical + Instruments GmbH, this system supports both proven and reliable LC-MS-based ClinMass kits and future chromatography-free DART-MS-based ClinDART kits, offering unmatched flexibility and throughput.
The double advantage of EVOQ® DART-TQ+
Bruker as a leading provider of mass spectrometry and RECIPE as a world-leader in clincial chemistry consumables have combined the reliability of kits for clinical research application with the analytical specificity and sensitivity of the EVOQ® DART-TQ+ triple quadrupole mass spectrometer.
The EVOQ® DART-TQ+ is the only instrument that can switch fast and easily between conventional LC-MS and fully integrated chromatography-free DART-MS technologies. Built for high-throughput analysis, it combines performance and ease-of-use in a reliable, low-maintenance platform that enables both established LC-MS methods, such as RECIPE's ClinMass, and transformative chromatography-free DART-MS workflows, such as the novel ClinDART kits.
ClinMass – proven workflows
ClinMass from RECIPE is a tried and trusted LC-MS based assay kit for small molecule analysis that enhances lab productivity by providing a reliable and reproducible LC-MS workflow.
- Well-established ClinMass kits are verified on the EVOQ® DART-TQ+
- Broad range of available kits
ClinDART – chromatography-free workflows for clinical research
ClinDART, the breakthrough innovation from Bruker and RECIPE, will bring chromatography-free analysis to use in a system that meets the needs of the fast-paced modern lab. By eliminating high-maintenance LC separation and enabling direct analysis of samples, the system delivers ultrafast results in a user-friendly, robust environment.
- Initial research studies demonstrate the potential of DART-MS in quantifying small molecules in serum, in a chromatography-free analysis.
- Analysis time of less than 30 sec per sample with highly reduced consumable needs. Cost-saving, robust and simple.
- Broad-range of future kits under development
Well-established LC-MS Kits – ClinMass
ClinMass assay kits from RECIPE represent a gold standard in LC-MS-based clinical research. Designed for high analytical specificity and reproducibility, these kits are fully compatible with the EVOQ® DART-TQ+ when operated with the HESI source.
With a growing portfolio of solutions, ClinMass provides a reliable path to proven LC-MS application workflows. As part of a dual-mode platform, ClinMass workflows can be seamlessly integrated today, while offering a future upgrade path to chromatography-free ClinDART kits on the same instrument.
- Compatible with EVOQ® DART-TQ+ using the VIP-HESI source
- Extensive range of available kits
Visit RECIPE’s website to explore and purchase ClinMass kits.
The ClinDART advantage
Bringing the power of mass spectrometry to clinical research labs in a fast and easy-to-use system, the future availability of Bruker-RECIPE ClinDART kits on an EVOQ® DART-TQ+ system will boost lab productivity.
Its simplified workflow is poised to accelerate high-throughput clinical research. ClinDART kits, launching soon, will enable chromatography-free workflows on the EVOQ® DART-TQ+ using Bruker’s DART source. This breakthrough simplifies sample prep and accelerates analysis.
High throughput
A full plate of 96 samples is analyzed in 42 min. A robot changes sample plates automatically for unattended high-throughput use.
Chromatography-free
Eliminating the need for chromatography in certain applications can simplify workflows, reduce costs and highly improve instrument uptime. The mass spectrometer can be operated by less experienced lab personal.
High performance
High sensitivity and robust quantitation in a system that is up to 15 times faster than LC-MS.
Sustainable
Reduced solvent consumption lowers costs, minimizes waste, and supports a more environmentally responsible workflow.
Accessible
From novice to experienced, the DART-MS technology aims to make mass spectrometry more accessible in clinical research settings.
ClinDART is poised to set new standards in high-throughput applications across clinical research and forensic laboratories (non-clinical). It offers new capabilities by delivering rapid, quantitative assays that redefine small molecule clinical research applications. Additionally, it supports fast and robust drugs of abuse screening, making it an ideal solution for high-throughput analysis.
Stay informed – Contact us to receive updates on ClinDART availability and validation progress.
Stay Connected – Be the First to Know
Whether you're ready to implement ClinMass workflows today or preparing for the launch of ClinDART, we’re here to support your journey. Get in touch with our team to learn more about the EVOQ® DART-TQ+ platform, request a demo, or subscribe for updates on the latest developments in chromatography-free mass spectrometry.
For Research Use Only. Not for use in clinical diagnostic procedures.